Initial Assessment of Non-nasal NK-cell Lymphomas & Aggressive NK-cell Leukemia/Lymphoma The evaluation for non-nasal NK-cell lymphomas and aggressive NK-cell leukemia/lymphoma is similar to that of ...
MIAMI, FL / ACCESS Newswire / November 21, 2025 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) (“Telomir” or the “Company”), a preclinical-stage biotechnology company developing small-molecule ...
Granulocyte colony-stimulating factor to be started on day 6. Cycles to be repeated every 28 days. SMILE: Dexamethasone, methotrexate, ifosfamide, L-asparaginase and etoposide. Stage I/II ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results